These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 32344398)
1. Profiling of the Risk Factors and Designing of a Model to Identify Ischemic Stroke in Patients with Non-Hodgkin Lymphoma: A Multicenter Retrospective Study. Wei Y; Yang Q; Qin Q; Chen Y; Quan X; Wei J; Zhou L; Wang D; Li H; Li G; Li S; Liang Z Eur Neurol; 2020; 83(1):41-48. PubMed ID: 32344398 [TBL] [Abstract][Full Text] [Related]
2. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin. Yamamoto R; Nakae Y; Tanaka F; Johkura K J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270 [TBL] [Abstract][Full Text] [Related]
3. Cancer-associated ischemic stroke is associated with elevated D-dimer and fibrin degradation product levels in acute ischemic stroke with advanced cancer. Kono T; Ohtsuki T; Hosomi N; Takeda I; Aoki S; Sueda Y; Ishihara K; Nakamura T; Yamawaki T; Matsumoto M Geriatr Gerontol Int; 2012 Jul; 12(3):468-74. PubMed ID: 22233138 [TBL] [Abstract][Full Text] [Related]
4. D-dimer >2.785 μg/ml and multiple infarcts ≥3 vascular territories are two characteristics of identifying cancer-associated ischemic stroke patients. Wang JY; Zhang GJ; Zhuo SX; Wang K; Hu XP; Zhang H; Qu LD Neurol Res; 2018 Nov; 40(11):948-954. PubMed ID: 30317943 [TBL] [Abstract][Full Text] [Related]
5. D-dimer and Body CT to Identify Occult Malignancy in Acute Ischemic Stroke. Rosenberg J; Do D; Cucchiara B; Messé SR J Stroke Cerebrovasc Dis; 2020 Dec; 29(12):105366. PubMed ID: 33039769 [TBL] [Abstract][Full Text] [Related]
6. The Potential Value of D-Dimer to Fibrinogen Ratio in Diagnosis of Acute Ischemic Stroke. Chen X; Li S; Chen W; Xu F; Wang Y; Zou G; Ren B J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):104918. PubMed ID: 32430237 [TBL] [Abstract][Full Text] [Related]
7. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma. Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197 [TBL] [Abstract][Full Text] [Related]
8. Active Cancer and Elevated D-Dimer Are Risk Factors for In-Hospital Ischemic Stroke. Yamaguchi I; Kanematsu Y; Shimada K; Korai M; Miyamoto T; Shikata E; Yamaguchi T; Yamamoto N; Yamamoto Y; Kitazato KT; Okayama Y; Takagi Y Cerebrovasc Dis Extra; 2019; 9(3):129-138. PubMed ID: 31760390 [TBL] [Abstract][Full Text] [Related]
10. Biomarkers and potential pathogenesis of colorectal cancer-related ischemic stroke. Qin QX; Cheng XM; Lu LZ; Wei YF; Wang DC; Li HH; Li GH; Liang HB; Li SY; Chen L; Liang ZJ World J Gastroenterol; 2018 Nov; 24(43):4950-4958. PubMed ID: 30487704 [TBL] [Abstract][Full Text] [Related]
11. Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Barber M; Langhorne P; Rumley A; Lowe GD; Stott DJ Stroke; 2004 Jun; 35(6):1421-5. PubMed ID: 15073383 [TBL] [Abstract][Full Text] [Related]
12. D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale. Kim YD; Song D; Nam HS; Lee K; Yoo J; Hong GR; Lee HS; Nam CM; Heo JH Thromb Haemost; 2015 Aug; 114(3):614-22. PubMed ID: 25994249 [TBL] [Abstract][Full Text] [Related]
13. Elevated plasma D-dimer levels are associated with short-term poor outcome in patients with acute ischemic stroke: a prospective, observational study. Yao T; Tian BL; Li G; Cui Q; Wang CF; Zhang Q; Peng B; Gao Y; Zhan YQ; Hu D; Xu L; Wang GH BMC Neurol; 2019 Jul; 19(1):175. PubMed ID: 31331288 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic value of coagulation index and serum inflammatory cytokines in hemorrhagic stroke patients with pulmonary infection in the sequelae stage. Wang Y; Li Y; Wang X; Niu Z; Zhou L Technol Health Care; 2024; 32(3):1383-1391. PubMed ID: 37661900 [TBL] [Abstract][Full Text] [Related]
17. Blood Biomarkers for the Early Diagnosis of Stroke: The Stroke-Chip Study. Bustamante A; López-Cancio E; Pich S; Penalba A; Giralt D; García-Berrocoso T; Ferrer-Costa C; Gasull T; Hernández-Pérez M; Millan M; Rubiera M; Cardona P; Cano L; Quesada H; Terceño M; Silva Y; Castellanos M; Garces M; Reverté S; Ustrell X; Marés R; Baiges JJ; Serena J; Rubio F; Salas E; Dávalos A; Montaner J Stroke; 2017 Sep; 48(9):2419-2425. PubMed ID: 28716979 [TBL] [Abstract][Full Text] [Related]
18. The role of hs-CRP, D-dimer and fibrinogen in differentiating etiological subtypes of ischemic stroke. Liu LB; Li M; Zhuo WY; Zhang YS; Xu AD PLoS One; 2015; 10(2):e0118301. PubMed ID: 25680111 [TBL] [Abstract][Full Text] [Related]
19. Clues to occult cancer in patients with ischemic stroke. Kim SJ; Park JH; Lee MJ; Park YG; Ahn MJ; Bang OY PLoS One; 2012; 7(9):e44959. PubMed ID: 22984594 [TBL] [Abstract][Full Text] [Related]
20. Impact of initial coagulation and fibrinolytic markers on mortality in patients with severe blunt trauma: a multicentre retrospective observational study. Ishii K; Kinoshita T; Kiridume K; Watanabe A; Yamakawa K; Nakao S; Fujimi S; Matsuoka T Scand J Trauma Resusc Emerg Med; 2019 Feb; 27(1):25. PubMed ID: 30819212 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]